N-substituted 4-(5-indolyl)benzoic acids.: Synthesis and evaluation of steroid 5α-reductase type I and II inhibitory activity

被引:40
作者
Baston, E [1 ]
Hartmann, RW [1 ]
机构
[1] Univ Saarland, Fachrichtung Pharmazeut & Med Chem 121, D-66041 Saarbrucken, Germany
关键词
D O I
10.1016/S0960-894X(99)00234-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of N-alkyl and N-arylalkyl substituted 4-(5-indolyl)benzoic acid derivatives as inhibitors of steroid 5 alpha-reductases is described. For the human type II isozyme a benzyl substituent (IC50 6.20 mu M) and for the human type I isozyme a cyclohexanemethyl substituent (IC50 2.10 mu M) on the indole nitrogen proved to be most efficacious, thus providing interesting leads for the development of drugs for the treatment of benign prostatic hyperplasia (BPH). (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1601 / 1606
页数:6
相关论文
共 20 条
  • [1] The development of non-steroidal dual inhibitors of both human 5 alpha-reductase isozymes
    Blagg, J
    Ballard, SA
    Cooper, K
    Finn, PW
    Johnson, PS
    MacIntyre, F
    Maw, GN
    Spargo, PL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (13) : 1517 - 1522
  • [2] 6-AZASTEROIDS - POTENT DUAL INHIBITORS OF HUMAN TYPE-1 AND 2 STEROID 5-ALPHA-REDUCTASE
    FRYE, SV
    HAFFNER, CD
    MALONEY, PR
    MOOK, RA
    HINER, RN
    BATCHELOR, KW
    BRAMSON, HN
    STUART, JD
    SCHWEIKER, SL
    VANARNOLD, J
    BICKETT, DM
    MOSS, ML
    TIAN, GC
    UNWALLA, RJ
    LEE, FW
    TIPPIN, TK
    JAMES, MK
    GRIZZLE, MK
    LONG, JE
    SCHUSTER, SV
    DORSEY, GF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (26) : 4313 - 4315
  • [3] 5 alpha-reductase inhibitors in prostate cancer
    Gormley, GJ
    [J]. ENDOCRINE-RELATED CANCER, 1996, 3 (01) : 57 - 63
  • [4] NOVEL 5-ALPHA-REDUCTASE INHIBITORS - SYNTHESIS AND STRUCTURE-ACTIVITY STUDIES OF 5-SUBSTITUTED 1-METHYL-2-PYRIDONES AND 1-METHYL-2-PIPERIDONES
    HARTMANN, RW
    REICHERT, M
    GOHRING, S
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (11) : 807 - 817
  • [5] FK143, A NOVEL NONSTEROIDAL INHIBITOR OF STEROID 5-REDUCTASE .1. IN-VITRO EFFECTS ON HUMAN AND ANIMAL PROSTATIC ENZYMES
    HIROSUMI, J
    NAKAYAMA, O
    FAGAN, T
    SAWADA, K
    CHIDA, N
    INAMI, M
    TAKAHASHI, S
    KOJO, H
    NOTSU, Y
    OKUHARA, M
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (04) : 357 - 363
  • [6] STEROIDAL A-RING ARYL CARBOXYLIC-ACIDS - A NEW CLASS OF STEROID 5-ALPHA-REDUCTASE INHIBITORS
    HOLT, DA
    LEVY, MA
    LADD, DL
    OH, HJ
    ERB, JM
    HEASLIP, JI
    BRANDT, M
    METCALF, BW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) : 937 - 942
  • [7] BENZOPHENONECARBOXYLIC AND INDOLECARBOXYLIC ACIDS - POTENT TYPE-2 SPECIFIC INHIBITORS OF HUMAN STEROID 5-ALPHA-REDUCTASE
    HOLT, DA
    YAMASHITA, DS
    KONIALIANBECK, AL
    LUENGO, JI
    ABELL, AD
    BERGSMA, DJ
    BRANDT, M
    LEVY, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) : 13 - 15
  • [8] HOLT KG, 1993, PHYS THER PRACT, V2, P1
  • [9] Pharmacokinetics and pharmacodynamics of FK143, a nonsteroidal inhibitor of steroid 5α-reductase, in healthy volunteers
    Katashima, M
    Irino, T
    Shimojo, F
    Kawamura, A
    Kageyama, H
    Higashi, N
    Miyao, Y
    Tokuma, Y
    Hata, T
    Yamamoto, K
    Sawada, Y
    Iga, T
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (03) : 354 - 366
  • [10] Pharmacological options in the treatment of benign prostatic hyperplasia
    Kenny, B
    Ballard, S
    Blagg, J
    Fox, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) : 1293 - 1315